Home Applications 209606 Application 209606
Type NDA
Sponsor CELGENE CORP Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 IDHIFA ENASIDENIB MESYLATE TABLET;ORAL EQ 50MG BASE Yes No 002 IDHIFA ENASIDENIB MESYLATE TABLET;ORAL EQ 100MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209606-001 IDHIFA ENASIDENIB MESYLATE EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 N209606-002 IDHIFA ENASIDENIB MESYLATE EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209606-001 10610125 2030-06-21 U-2087 2020-05-01 N209606-001 10294215 2033-01-07 U-2087 Drug product 2019-06-20 N209606-001 9512107 2033-01-07 U-2087 Drug substance, Drug product 2017-08-29 N209606-001 10093654 2034-08-01 U-2087 Drug substance, Drug product 2018-11-07 N209606-001 9738625 2034-08-01 Drug substance 2017-08-29 N209606-001 9732062 2034-09-16 Drug substance 2017-08-29 N209606-002 10610125 2030-06-21 U-2087 2020-05-01 N209606-002 10294215 2033-01-07 U-2087 Drug product 2019-06-20 N209606-002 9512107 2033-01-07 U-2087 Drug substance, Drug product 2017-08-29 N209606-002 10093654 2034-08-01 U-2087 Drug substance, Drug product 2018-11-07 N209606-002 9738625 2034-08-01 Drug substance 2017-08-29 N209606-002 9732062 2034-09-16 Drug substance 2017-08-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 82 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N209606-001 IDHIFA EQ 50MG BASE TABLET / ORAL RLD 2017-08-01 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N209606-002 IDHIFA EQ 100MG BASE TABLET / ORAL RLD, RS 2017-08-01 782e0a99824c…
Observed Orange Book patent history# Patent history page 1 of 13 · 484 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N209606-001 10610125 2030-06-21 U-2087 2020-05-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-001 10294215 2033-01-07 U-2087 Drug product 2019-06-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-001 9512107 2033-01-07 U-2087 Drug substance, Drug product 2017-08-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-001 10093654 2034-08-01 U-2087 Drug substance, Drug product 2018-11-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-001 9738625 2034-08-01 Drug substance 2017-08-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-001 9732062 2034-09-16 Drug substance 2017-08-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-002 10610125 2030-06-21 U-2087 2020-05-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-002 10294215 2033-01-07 U-2087 Drug product 2019-06-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-002 9512107 2033-01-07 U-2087 Drug substance, Drug product 2017-08-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-002 10093654 2034-08-01 U-2087 Drug substance, Drug product 2018-11-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-002 9738625 2034-08-01 Drug substance 2017-08-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209606-002 9732062 2034-09-16 Drug substance 2017-08-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-001 10610125 2030-06-21 U-2087 2020-05-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-001 10294215 2033-01-07 U-2087 Drug product 2019-06-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-001 9512107 2033-01-07 U-2087 Drug substance, Drug product 2017-08-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-001 10093654 2034-08-01 U-2087 Drug substance, Drug product 2018-11-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-001 9738625 2034-08-01 Drug substance 2017-08-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-001 9732062 2034-09-16 Drug substance 2017-08-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-002 10610125 2030-06-21 U-2087 2020-05-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-002 10294215 2033-01-07 U-2087 Drug product 2019-06-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-002 9512107 2033-01-07 U-2087 Drug substance, Drug product 2017-08-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-002 10093654 2034-08-01 U-2087 Drug substance, Drug product 2018-11-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-002 9738625 2034-08-01 Drug substance 2017-08-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209606-002 9732062 2034-09-16 Drug substance 2017-08-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209606-001 10610125 2030-06-21 U-2087 2020-05-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-001 10294215 2033-01-07 U-2087 Drug product 2019-06-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-001 9512107 2033-01-07 U-2087 Drug substance, Drug product 2017-08-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-001 10093654 2034-08-01 U-2087 Drug substance, Drug product 2018-11-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-001 9738625 2034-08-01 Drug substance 2017-08-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-001 9732062 2034-09-16 Drug substance 2017-08-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-002 10610125 2030-06-21 U-2087 2020-05-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-002 10294215 2033-01-07 U-2087 Drug product 2019-06-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-002 9512107 2033-01-07 U-2087 Drug substance, Drug product 2017-08-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-002 10093654 2034-08-01 U-2087 Drug substance, Drug product 2018-11-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-002 9738625 2034-08-01 Drug substance 2017-08-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209606-002 9732062 2034-09-16 Drug substance 2017-08-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209606-001 10610125 2030-06-21 U-2087 2020-05-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209606-001 10294215 2033-01-07 U-2087 Drug product 2019-06-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209606-001 9512107 2033-01-07 U-2087 Drug substance, Drug product 2017-08-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209606-001 10093654 2034-08-01 U-2087 Drug substance, Drug product 2018-11-07 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 106 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 10 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 59572-705 Idhifa enasidenib mesylate Celgene Corporation NDA Current 59572-705 Idhifa enasidenib mesylate Celgene Corporation NDA Current 59572-705 Idhifa enasidenib mesylate Celgene Corporation NDA Current 59572-705 Idhifa enasidenib mesylate Celgene Corporation NDA Current 59572-705 Idhifa enasidenib mesylate Celgene Corporation NDA Current 59572-710 Idhifa enasidenib mesylate Celgene Corporation NDA Current 59572-710 Idhifa enasidenib mesylate Celgene Corporation NDA Current 59572-710 Idhifa enasidenib mesylate Celgene Corporation NDA Current 59572-710 Idhifa enasidenib mesylate Celgene Corporation NDA Current 59572-710 Idhifa enasidenib mesylate Celgene Corporation NDA Current